Shu Ling Chiang
Presidente presso BIOFIRST CORP
Profilo
Shu Ling Chiang is currently the Chairman at BioFirst Corp.
and a Director at both ABVC BioPharma, Inc. and BioLite, Inc. She graduated from Northwestern University in 1983 with a graduate degree and from National Taiwan Normal University in 1978 with an undergraduate degree.
Posizioni attive di Shu Ling Chiang
| Società | Posizione | Inizio |
|---|---|---|
| BIOFIRST CORP | Presidente | 01/01/2017 |
| ABVC BIOPHARMA, INC. | Direttore/Membro del Consiglio | - |
BioLite, Inc. /Taiwan/
 BioLite, Inc. /Taiwan/ Pharmaceuticals: GenericHealth Technology Founded in 1995, BioLite, Inc. /Taiwan/ is a Taiwanese company that specializes in advanced biomedical technology. Part of ABVC BioPharma, Inc., the company is based in Taipei, Taiwan. The description of the company is "????????????", which translates to "Lite Advanced Biomedical Co., Ltd." in English. BioLite, Inc. /Taiwan was acquired by ABVC BioPharma, Inc. on December 31, 2022. | Direttore/Membro del Consiglio | - |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 01/01/2022 |
Formazione di Shu Ling Chiang
| National Taiwan Normal University | Undergraduate Degree |
| Northwestern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABVC BIOPHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
BioFirst Corp.
 BioFirst Corp. BiotechnologyHealth Technology BioFirst Corp. engages in the research and development, manufacture and sale of medical equipment and medicines. Its products include testing equipment and reagents, vitreous filler, and Nano drug carriers. The company is the agent of Infopia's Clover AlcSelf glycosylated hemoglobin real time detection system, Infopia's GluKoPetA1c animal hemoglobin detection system, and BioPredictive's FibroTest and FibroMax liver fibrosis assessment tools. The company was founded on November 7, 2006 and is headquartered in Taipei, Taiwan. | Health Technology |
BioLite, Inc. /Taiwan/
BioLite, Inc. /Taiwan/ Pharmaceuticals: GenericHealth Technology Founded in 1995, BioLite, Inc. /Taiwan/ is a Taiwanese company that specializes in advanced biomedical technology. Part of ABVC BioPharma, Inc., the company is based in Taipei, Taiwan. The description of the company is "????????????", which translates to "Lite Advanced Biomedical Co., Ltd." in English. BioLite, Inc. /Taiwan was acquired by ABVC BioPharma, Inc. on December 31, 2022. | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Shu Ling Chiang
